Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
NF-kappa B | 31 | 2007 | 306 | 3.470 |
Why?
|
Curcumin | 13 | 2012 | 66 | 2.150 |
Why?
|
Apoptosis | 22 | 2016 | 1317 | 1.570 |
Why?
|
Antineoplastic Agents | 15 | 2016 | 756 | 1.370 |
Why?
|
Neoplasms | 14 | 2016 | 1033 | 1.250 |
Why?
|
Commiphora | 3 | 2016 | 5 | 1.210 |
Why?
|
Pregnenediones | 3 | 2016 | 5 | 1.120 |
Why?
|
I-kappa B Kinase | 12 | 2006 | 40 | 0.980 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 4 | 2006 | 82 | 0.740 |
Why?
|
Cyclin D1 | 7 | 2006 | 42 | 0.710 |
Why?
|
Lung Neoplasms | 6 | 2006 | 336 | 0.700 |
Why?
|
Tumor Necrosis Factor-alpha | 12 | 2007 | 325 | 0.640 |
Why?
|
Isoenzymes | 5 | 2004 | 149 | 0.630 |
Why?
|
I-kappa B Proteins | 8 | 2006 | 38 | 0.600 |
Why?
|
Cyclooxygenase Inhibitors | 3 | 2007 | 28 | 0.590 |
Why?
|
Down-Regulation | 12 | 2007 | 420 | 0.580 |
Why?
|
Cyclooxygenase 2 | 12 | 2007 | 92 | 0.580 |
Why?
|
Gene Expression | 6 | 2012 | 639 | 0.570 |
Why?
|
Transcription Factors | 5 | 2012 | 653 | 0.550 |
Why?
|
Triterpenes | 2 | 2006 | 12 | 0.520 |
Why?
|
Plant Gums | 2 | 2016 | 7 | 0.480 |
Why?
|
Sulfonamides | 2 | 2004 | 75 | 0.480 |
Why?
|
Phosphorylation | 13 | 2006 | 878 | 0.480 |
Why?
|
Prostaglandin-Endoperoxide Synthases | 5 | 2004 | 33 | 0.470 |
Why?
|
Enzyme Activation | 14 | 2007 | 423 | 0.470 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2004 | 166 | 0.450 |
Why?
|
Matrix Metalloproteinase 9 | 6 | 2006 | 88 | 0.440 |
Why?
|
Cell Line, Tumor | 16 | 2016 | 2128 | 0.430 |
Why?
|
Gene Expression Regulation | 5 | 2012 | 968 | 0.410 |
Why?
|
Humans | 49 | 2021 | 34853 | 0.390 |
Why?
|
Cell Proliferation | 10 | 2016 | 1149 | 0.370 |
Why?
|
Plant Extracts | 4 | 2008 | 250 | 0.360 |
Why?
|
S Phase | 3 | 2007 | 36 | 0.360 |
Why?
|
Proto-Oncogene Proteins c-akt | 8 | 2007 | 245 | 0.350 |
Why?
|
Osteoclasts | 4 | 2007 | 13 | 0.330 |
Why?
|
Smoking | 3 | 2004 | 903 | 0.330 |
Why?
|
Anticarcinogenic Agents | 2 | 2006 | 65 | 0.330 |
Why?
|
Animals | 21 | 2021 | 14307 | 0.330 |
Why?
|
Klebsiella pneumoniae | 2 | 2018 | 16 | 0.320 |
Why?
|
Chemistry, Pharmaceutical | 1 | 2007 | 65 | 0.310 |
Why?
|
Dust | 2 | 2018 | 51 | 0.310 |
Why?
|
Pseudomonas aeruginosa | 2 | 2018 | 57 | 0.310 |
Why?
|
Transcription Factor RelA | 6 | 2006 | 37 | 0.290 |
Why?
|
Genes, Reporter | 7 | 2007 | 132 | 0.290 |
Why?
|
Signal Transduction | 8 | 2007 | 1802 | 0.290 |
Why?
|
Drug Design | 1 | 2007 | 154 | 0.290 |
Why?
|
G1 Phase | 2 | 2005 | 32 | 0.290 |
Why?
|
Oleanolic Acid | 1 | 2006 | 3 | 0.290 |
Why?
|
Tumor Necrosis Factors | 1 | 2006 | 12 | 0.290 |
Why?
|
Carcinogens | 2 | 2004 | 117 | 0.280 |
Why?
|
Chronic Disease | 2 | 2008 | 469 | 0.280 |
Why?
|
Fenretinide | 1 | 2005 | 8 | 0.280 |
Why?
|
Lymphoma, Mantle-Cell | 1 | 2005 | 4 | 0.280 |
Why?
|
Cell Survival | 9 | 2007 | 818 | 0.270 |
Why?
|
Membrane Proteins | 7 | 2007 | 486 | 0.270 |
Why?
|
Biological Factors | 1 | 2004 | 6 | 0.260 |
Why?
|
Spices | 1 | 2004 | 8 | 0.260 |
Why?
|
Escherichia coli | 2 | 2018 | 436 | 0.260 |
Why?
|
Promoter Regions, Genetic | 6 | 2006 | 484 | 0.250 |
Why?
|
Antineoplastic Agents, Phytogenic | 4 | 2008 | 107 | 0.250 |
Why?
|
Atherosclerosis | 1 | 2005 | 131 | 0.250 |
Why?
|
Proto-Oncogene Proteins | 2 | 2005 | 229 | 0.240 |
Why?
|
Plant Roots | 1 | 2005 | 153 | 0.230 |
Why?
|
Neoplasm Proteins | 2 | 2004 | 203 | 0.230 |
Why?
|
Myocardial Infarction | 1 | 2005 | 221 | 0.230 |
Why?
|
Precancerous Conditions | 3 | 2007 | 81 | 0.210 |
Why?
|
Interleukin-1 | 4 | 2006 | 33 | 0.200 |
Why?
|
Active Transport, Cell Nucleus | 3 | 2006 | 54 | 0.200 |
Why?
|
Metals, Heavy | 1 | 2021 | 56 | 0.190 |
Why?
|
Epithelial Cells | 3 | 2018 | 366 | 0.190 |
Why?
|
Neoplasm Invasiveness | 3 | 2006 | 247 | 0.190 |
Why?
|
Soil Pollutants | 1 | 2021 | 86 | 0.190 |
Why?
|
Stilbenes | 3 | 2006 | 41 | 0.190 |
Why?
|
Cyclonic Storms | 1 | 2021 | 62 | 0.190 |
Why?
|
Inflammation | 4 | 2006 | 577 | 0.190 |
Why?
|
Neovascularization, Pathologic | 2 | 2016 | 122 | 0.190 |
Why?
|
Diet | 1 | 2006 | 747 | 0.180 |
Why?
|
Neoplasm Metastasis | 3 | 2005 | 211 | 0.180 |
Why?
|
Gene Expression Regulation, Neoplastic | 6 | 2007 | 781 | 0.170 |
Why?
|
Blotting, Western | 7 | 2007 | 834 | 0.170 |
Why?
|
Eukaryotic Cells | 1 | 2018 | 32 | 0.170 |
Why?
|
Biofilms | 2 | 2017 | 166 | 0.160 |
Why?
|
Models, Biological | 3 | 2007 | 642 | 0.160 |
Why?
|
Enterococcus faecalis | 1 | 2018 | 36 | 0.160 |
Why?
|
DNA-Binding Proteins | 4 | 2010 | 522 | 0.160 |
Why?
|
Vascular Endothelial Growth Factor A | 3 | 2007 | 157 | 0.150 |
Why?
|
Environmental Exposure | 2 | 2017 | 207 | 0.150 |
Why?
|
Receptors, Tumor Necrosis Factor | 3 | 2006 | 32 | 0.150 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2016 | 242 | 0.150 |
Why?
|
Carcinoma, Small Cell | 2 | 2006 | 6 | 0.150 |
Why?
|
Transcription Factor AP-1 | 2 | 2007 | 33 | 0.150 |
Why?
|
Membrane Glycoproteins | 4 | 2006 | 197 | 0.140 |
Why?
|
U937 Cells | 3 | 2006 | 27 | 0.140 |
Why?
|
Cell Division | 4 | 2004 | 296 | 0.140 |
Why?
|
Resins, Plant | 1 | 2016 | 3 | 0.140 |
Why?
|
Mouth Neoplasms | 2 | 2007 | 70 | 0.140 |
Why?
|
Molecular Structure | 2 | 2016 | 467 | 0.140 |
Why?
|
Jurkat Cells | 3 | 2004 | 72 | 0.140 |
Why?
|
Air Microbiology | 1 | 2015 | 12 | 0.140 |
Why?
|
Multiple Myeloma | 2 | 2006 | 32 | 0.130 |
Why?
|
Dose-Response Relationship, Drug | 7 | 2007 | 984 | 0.130 |
Why?
|
Cell Line | 4 | 2018 | 1289 | 0.130 |
Why?
|
Okadaic Acid | 2 | 2004 | 12 | 0.130 |
Why?
|
Tetradecanoylphorbol Acetate | 2 | 2004 | 39 | 0.130 |
Why?
|
Transcription, Genetic | 3 | 2010 | 550 | 0.130 |
Why?
|
Air Pollutants | 1 | 2015 | 90 | 0.130 |
Why?
|
Carrier Proteins | 3 | 2006 | 287 | 0.130 |
Why?
|
Cell Nucleus | 3 | 2006 | 351 | 0.120 |
Why?
|
Pyrazoles | 2 | 2004 | 80 | 0.120 |
Why?
|
Luciferases | 2 | 2004 | 62 | 0.120 |
Why?
|
Receptors, Growth Factor | 1 | 2012 | 13 | 0.110 |
Why?
|
Medicine, Traditional | 1 | 2012 | 20 | 0.110 |
Why?
|
Proteins | 3 | 2004 | 352 | 0.110 |
Why?
|
Tumor Cells, Cultured | 7 | 2007 | 480 | 0.110 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 3 | 2007 | 73 | 0.110 |
Why?
|
Receptor Activator of Nuclear Factor-kappa B | 3 | 2006 | 4 | 0.100 |
Why?
|
RANK Ligand | 3 | 2006 | 13 | 0.100 |
Why?
|
Poly(ADP-ribose) Polymerases | 3 | 2010 | 72 | 0.100 |
Why?
|
Inflammation Mediators | 1 | 2012 | 120 | 0.100 |
Why?
|
Drug Synergism | 3 | 2006 | 171 | 0.100 |
Why?
|
Radiation Injuries, Experimental | 1 | 2010 | 4 | 0.100 |
Why?
|
Protons | 1 | 2010 | 80 | 0.090 |
Why?
|
Tobacco, Smokeless | 2 | 2007 | 18 | 0.090 |
Why?
|
Osteogenesis | 2 | 2006 | 31 | 0.090 |
Why?
|
Cyclin E | 2 | 2006 | 13 | 0.090 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p27 | 2 | 2006 | 21 | 0.090 |
Why?
|
Medicine, Ayurvedic | 2 | 2006 | 5 | 0.090 |
Why?
|
Genes, myc | 2 | 2006 | 28 | 0.090 |
Why?
|
DNA Repair | 1 | 2010 | 181 | 0.090 |
Why?
|
Boronic Acids | 2 | 2006 | 19 | 0.090 |
Why?
|
Pyrazines | 2 | 2006 | 23 | 0.090 |
Why?
|
Immunohistochemistry | 6 | 2007 | 859 | 0.090 |
Why?
|
STAT3 Transcription Factor | 2 | 2006 | 80 | 0.080 |
Why?
|
Clinical Trials as Topic | 2 | 2007 | 195 | 0.080 |
Why?
|
Drug Resistance, Neoplasm | 3 | 2006 | 209 | 0.080 |
Why?
|
Mitogen-Activated Protein Kinases | 2 | 2006 | 122 | 0.080 |
Why?
|
Antigens, CD20 | 1 | 2007 | 4 | 0.080 |
Why?
|
Coculture Techniques | 2 | 2018 | 96 | 0.080 |
Why?
|
TNF Receptor-Associated Factor 2 | 2 | 2004 | 16 | 0.080 |
Why?
|
Antibiotics, Antineoplastic | 2 | 2006 | 41 | 0.080 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 2 | 2004 | 19 | 0.080 |
Why?
|
DNA, Neoplasm | 2 | 2004 | 86 | 0.080 |
Why?
|
Doxorubicin | 2 | 2006 | 80 | 0.080 |
Why?
|
Oncogene Proteins | 1 | 2006 | 18 | 0.080 |
Why?
|
Angiogenesis Inhibitors | 1 | 2007 | 56 | 0.080 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2007 | 107 | 0.070 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2006 | 54 | 0.070 |
Why?
|
Rotenone | 1 | 2006 | 18 | 0.070 |
Why?
|
Drug Delivery Systems | 2 | 2006 | 182 | 0.070 |
Why?
|
Proto-Oncogene Proteins c-fos | 1 | 2007 | 74 | 0.070 |
Why?
|
PTEN Phosphohydrolase | 1 | 2007 | 53 | 0.070 |
Why?
|
Cell Migration Inhibition | 1 | 2006 | 5 | 0.070 |
Why?
|
Withania | 1 | 2006 | 4 | 0.070 |
Why?
|
Ergosterol | 1 | 2006 | 10 | 0.070 |
Why?
|
Biphenyl Compounds | 1 | 2006 | 52 | 0.070 |
Why?
|
TNF Receptor-Associated Death Domain Protein | 1 | 2006 | 1 | 0.070 |
Why?
|
Lignans | 1 | 2006 | 21 | 0.070 |
Why?
|
DNA Primers | 2 | 2005 | 269 | 0.070 |
Why?
|
Central Nervous System Neoplasms | 1 | 2006 | 9 | 0.070 |
Why?
|
Glioma | 1 | 2007 | 76 | 0.070 |
Why?
|
Cells, Cultured | 3 | 2006 | 1442 | 0.070 |
Why?
|
DNA Replication | 1 | 2007 | 148 | 0.070 |
Why?
|
Chemoprevention | 1 | 2006 | 34 | 0.070 |
Why?
|
Mutation | 2 | 2007 | 1023 | 0.070 |
Why?
|
Cell Growth Processes | 1 | 2005 | 41 | 0.070 |
Why?
|
Tobacco Smoke Pollution | 1 | 2006 | 45 | 0.070 |
Why?
|
Oncogene Protein v-akt | 1 | 2005 | 19 | 0.070 |
Why?
|
Tetrazoles | 1 | 2006 | 49 | 0.070 |
Why?
|
Leukemia | 1 | 2006 | 54 | 0.070 |
Why?
|
India | 1 | 2005 | 82 | 0.070 |
Why?
|
Molecular Biology | 1 | 2006 | 44 | 0.070 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2007 | 176 | 0.070 |
Why?
|
Paclitaxel | 1 | 2005 | 48 | 0.070 |
Why?
|
Glioblastoma | 1 | 2006 | 49 | 0.070 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2005 | 52 | 0.070 |
Why?
|
Imidazoles | 1 | 2006 | 124 | 0.070 |
Why?
|
Multiple Sclerosis | 1 | 2005 | 43 | 0.070 |
Why?
|
Arthritis, Rheumatoid | 1 | 2005 | 52 | 0.070 |
Why?
|
Mammary Neoplasms, Experimental | 1 | 2005 | 70 | 0.070 |
Why?
|
Recombinant Fusion Proteins | 1 | 2006 | 286 | 0.070 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2006 | 112 | 0.070 |
Why?
|
Electrophoretic Mobility Shift Assay | 4 | 2005 | 52 | 0.060 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2004 | 605 | 0.060 |
Why?
|
TNF Receptor-Associated Factor 1 | 1 | 2004 | 3 | 0.060 |
Why?
|
Vegetables | 1 | 2006 | 135 | 0.060 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2004 | 21 | 0.060 |
Why?
|
Fruit | 1 | 2006 | 159 | 0.060 |
Why?
|
Immunity | 1 | 2004 | 51 | 0.060 |
Why?
|
Biology | 1 | 2004 | 15 | 0.060 |
Why?
|
Melanoma | 1 | 2005 | 91 | 0.060 |
Why?
|
Daunorubicin | 1 | 2004 | 3 | 0.060 |
Why?
|
Disease | 1 | 2004 | 18 | 0.060 |
Why?
|
Fusion Proteins, bcr-abl | 1 | 2004 | 9 | 0.060 |
Why?
|
Smoke | 1 | 2004 | 39 | 0.060 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2004 | 29 | 0.060 |
Why?
|
Blood Glucose | 1 | 2005 | 333 | 0.060 |
Why?
|
Leukemia, Myeloid | 1 | 2003 | 8 | 0.060 |
Why?
|
Protein Structure, Tertiary | 1 | 2004 | 383 | 0.060 |
Why?
|
Temperature | 1 | 2004 | 275 | 0.060 |
Why?
|
Protein Processing, Post-Translational | 1 | 2004 | 162 | 0.060 |
Why?
|
Pancreatic Neoplasms | 1 | 2004 | 106 | 0.060 |
Why?
|
Models, Chemical | 1 | 2004 | 201 | 0.060 |
Why?
|
Piperazines | 1 | 2004 | 109 | 0.060 |
Why?
|
Pyrimidines | 1 | 2004 | 112 | 0.060 |
Why?
|
Lipopolysaccharides | 1 | 2004 | 200 | 0.060 |
Why?
|
MAP Kinase Signaling System | 1 | 2004 | 162 | 0.060 |
Why?
|
Trans-Activators | 1 | 2003 | 167 | 0.060 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2003 | 184 | 0.060 |
Why?
|
Gene Deletion | 1 | 2002 | 156 | 0.050 |
Why?
|
Transfection | 1 | 2003 | 496 | 0.050 |
Why?
|
Mice | 6 | 2010 | 5668 | 0.050 |
Why?
|
Rivers | 1 | 2021 | 43 | 0.050 |
Why?
|
Oxidative Stress | 2 | 2017 | 874 | 0.050 |
Why?
|
Hypertension | 1 | 2007 | 770 | 0.050 |
Why?
|
Soil | 1 | 2021 | 129 | 0.050 |
Why?
|
Environmental Monitoring | 1 | 2021 | 188 | 0.050 |
Why?
|
RNA, Messenger | 1 | 2003 | 1152 | 0.040 |
Why?
|
Brain | 1 | 2006 | 1268 | 0.040 |
Why?
|
Alzheimer Disease | 1 | 2005 | 881 | 0.040 |
Why?
|
Female | 6 | 2007 | 19873 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2005 | 592 | 0.040 |
Why?
|
HT29 Cells | 1 | 2017 | 40 | 0.040 |
Why?
|
Environmental Microbiology | 1 | 2017 | 26 | 0.040 |
Why?
|
Gastrointestinal Tract | 1 | 2017 | 59 | 0.040 |
Why?
|
Hydrogen Peroxide | 1 | 2017 | 181 | 0.040 |
Why?
|
Up-Regulation | 2 | 2010 | 490 | 0.040 |
Why?
|
Tumor Suppressor Proteins | 2 | 2010 | 184 | 0.030 |
Why?
|
Time Factors | 3 | 2007 | 1681 | 0.030 |
Why?
|
Syndecan-1 | 2 | 2006 | 9 | 0.030 |
Why?
|
Lung | 1 | 2018 | 413 | 0.030 |
Why?
|
Male | 7 | 2010 | 18870 | 0.030 |
Why?
|
Cell Cycle Proteins | 2 | 2010 | 220 | 0.030 |
Why?
|
Particulate Matter | 1 | 2015 | 49 | 0.030 |
Why?
|
Air Pollution, Indoor | 1 | 2015 | 40 | 0.030 |
Why?
|
Interleukin-8 | 2 | 2005 | 59 | 0.030 |
Why?
|
Transcriptional Activation | 2 | 2007 | 164 | 0.030 |
Why?
|
Interleukin-6 | 2 | 2006 | 140 | 0.030 |
Why?
|
Flow Cytometry | 2 | 2005 | 392 | 0.030 |
Why?
|
Aged | 4 | 2007 | 6448 | 0.030 |
Why?
|
Ligands | 2 | 2003 | 317 | 0.030 |
Why?
|
Xeroderma Pigmentosum Group A Protein | 1 | 2010 | 3 | 0.020 |
Why?
|
Endonucleases | 1 | 2010 | 18 | 0.020 |
Why?
|
Middle Aged | 4 | 2007 | 9642 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2010 | 649 | 0.020 |
Why?
|
DNA Damage | 1 | 2010 | 341 | 0.020 |
Why?
|
Nitrosamines | 1 | 2007 | 9 | 0.020 |
Why?
|
Oligonucleotides | 1 | 2007 | 48 | 0.020 |
Why?
|
Bone Resorption | 1 | 2007 | 7 | 0.020 |
Why?
|
Thalidomide | 1 | 2006 | 4 | 0.020 |
Why?
|
Genes, erbB-1 | 1 | 2006 | 3 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2010 | 600 | 0.020 |
Why?
|
Cytoplasm | 1 | 2007 | 135 | 0.020 |
Why?
|
Genes, ras | 1 | 2006 | 22 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2007 | 213 | 0.020 |
Why?
|
Synaptotagmin I | 1 | 2006 | 3 | 0.020 |
Why?
|
bcl-2-Associated X Protein | 1 | 2006 | 72 | 0.020 |
Why?
|
Microscopy, Confocal | 1 | 2007 | 210 | 0.020 |
Why?
|
Interleukins | 1 | 2006 | 28 | 0.020 |
Why?
|
Ubiquitin | 1 | 2006 | 76 | 0.020 |
Why?
|
Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2006 | 9 | 0.020 |
Why?
|
Drug Interactions | 1 | 2006 | 137 | 0.020 |
Why?
|
Glycogen Synthase Kinase 3 | 1 | 2006 | 27 | 0.020 |
Why?
|
Caspase 3 | 1 | 2006 | 194 | 0.020 |
Why?
|
Epidermal Growth Factor | 1 | 2006 | 63 | 0.020 |
Why?
|
Lymphocytes | 1 | 2006 | 116 | 0.020 |
Why?
|
Serine | 1 | 2006 | 72 | 0.020 |
Why?
|
Ki-67 Antigen | 1 | 2005 | 32 | 0.020 |
Why?
|
Lipid Peroxidation | 1 | 2006 | 131 | 0.020 |
Why?
|
Adult | 3 | 2007 | 11034 | 0.020 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2005 | 23 | 0.020 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2005 | 90 | 0.020 |
Why?
|
Veratrum | 1 | 2004 | 1 | 0.020 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2006 | 146 | 0.020 |
Why?
|
Anti-Inflammatory Agents | 1 | 2006 | 137 | 0.020 |
Why?
|
Mice, Nude | 1 | 2005 | 323 | 0.020 |
Why?
|
Protein Transport | 1 | 2005 | 286 | 0.020 |
Why?
|
Immunoblotting | 1 | 2004 | 170 | 0.020 |
Why?
|
Leukemia, Myelomonocytic, Chronic | 1 | 2004 | 2 | 0.020 |
Why?
|
Myelodysplastic Syndromes | 1 | 2004 | 4 | 0.020 |
Why?
|
Philadelphia Chromosome | 1 | 2004 | 3 | 0.020 |
Why?
|
Anthracyclines | 1 | 2004 | 5 | 0.020 |
Why?
|
Protein Binding | 1 | 2007 | 913 | 0.020 |
Why?
|
Terminal Repeat Sequences | 1 | 2004 | 8 | 0.020 |
Why?
|
Syndecans | 1 | 2003 | 2 | 0.020 |
Why?
|
Cyclin D3 | 1 | 2003 | 2 | 0.020 |
Why?
|
Karyotyping | 1 | 2004 | 46 | 0.020 |
Why?
|
TNF Receptor-Associated Factor 6 | 1 | 2003 | 4 | 0.020 |
Why?
|
Annexin A5 | 1 | 2003 | 24 | 0.020 |
Why?
|
Tetrazolium Salts | 1 | 2003 | 36 | 0.020 |
Why?
|
In Situ Hybridization | 1 | 2004 | 125 | 0.020 |
Why?
|
Cyclins | 1 | 2003 | 35 | 0.020 |
Why?
|
Blotting, Northern | 1 | 2004 | 139 | 0.020 |
Why?
|
Dexamethasone | 1 | 2003 | 43 | 0.010 |
Why?
|
Coloring Agents | 1 | 2003 | 51 | 0.010 |
Why?
|
Dimerization | 1 | 2003 | 102 | 0.010 |
Why?
|
Inhibitory Concentration 50 | 1 | 2003 | 81 | 0.010 |
Why?
|
Proteoglycans | 1 | 2003 | 46 | 0.010 |
Why?
|
Reactive Oxygen Species | 1 | 2006 | 416 | 0.010 |
Why?
|
Fluorescent Antibody Technique | 1 | 2004 | 185 | 0.010 |
Why?
|
Bone Marrow Cells | 1 | 2003 | 75 | 0.010 |
Why?
|
Base Sequence | 1 | 2005 | 932 | 0.010 |
Why?
|
Thiazoles | 1 | 2003 | 71 | 0.010 |
Why?
|
Bone Marrow | 1 | 2003 | 34 | 0.010 |
Why?
|
Benzamides | 1 | 2004 | 76 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2004 | 139 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2004 | 445 | 0.010 |
Why?
|
Acute Disease | 1 | 2003 | 141 | 0.010 |
Why?
|
Cell Adhesion | 1 | 2003 | 209 | 0.010 |
Why?
|
Cell Death | 1 | 2003 | 260 | 0.010 |
Why?
|
Protein Subunits | 1 | 2002 | 85 | 0.010 |
Why?
|
Prognosis | 1 | 2004 | 707 | 0.010 |
Why?
|
Hela Cells | 1 | 2002 | 344 | 0.010 |
Why?
|
Peptides | 1 | 2003 | 308 | 0.010 |
Why?
|
DNA | 1 | 2003 | 549 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2003 | 562 | 0.010 |
Why?
|
Phenotype | 1 | 2002 | 650 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2004 | 2333 | 0.010 |
Why?
|
Child | 1 | 2004 | 2875 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2005 | 1426 | 0.010 |
Why?
|
Adolescent | 1 | 2004 | 5035 | 0.010 |
Why?
|